Masterclass on Biologics — towards personalised medicine
In this one day course key opinion leaders in the biologics field will share the latest information on pharmacokinetics (PK) and immunogenicity of biologics.
In depth information on assay formats and how to interpret PK and anti-drug antibody (ADA) data will be shared with a focus on antibody therapy in oncology and rheumatoid arthritis.
In this masterclass clinical practice and background knowledge will be shared and discussed.
Professor ADR Huitema, Clinical Pharmacologist at the Netherlands Cancer Institute/Utrecht University will give insight into TDM of biologics in oncology.
Dr Gertjan Wolbink, Rheumatologist at the Jan van Breemen Research Institute/ Reade/Sanquin willl explain how to use serum measurements PK/ADA in the clinic towards personalised medicine.
More in depth information on assay/ assay formats and how to interpret the data will be given by Dr Theo Rispens, Sanquin Research and Dr Annick de Vries (Sanquin Diagnostic Services) and other Sanquin team members.
There will be a lot of time for discussion and answering of questions on Biologics.
The following topics will be covered:
- Immunogenicity and TNF-blockers
- Pharmacokinetics of Biologics - from TNF inhibitors to PD-1 inhibitors
- Therapeutic drug monitoring
- Antibody therapy in Oncology and Inflammatory diseases (IBD, MS, RA)
- Biosimilars
- How to use serum PK and ADA measurements in the clinic
- The latest developments in PK and ADA measurements
- Natalizumab PK/ADA
There will also be the opportunity to visit the Sanquin Laboratories and ample networking opportunities.
Event venue: Plesmanlaan 125, 1066 CX Amsterdam
Organiser: Sanquin
Email: biologics@sanquin.nl
Web: www.Sanquin.nl
